🇳🇬 PCN Licensed: LAG20247B39C9 📍 17 Ademola Osinowo Street, Ikosi Ketu, Lagos 📞 +234 705 050 5001 ✉ care@hubpharmafrica.com ⚡ Same-Day Delivery in Lagos 🌍 Serving patients in 31 countries 💊 10,200+ Chronic Care Patients ✅ NAFDAC & HIPAA Compliant 🇳🇬 PCN Licensed: LAG20247B39C9 📍 17 Ademola Osinowo Street, Ikosi Ketu, Lagos 📞 +234 705 050 5001 ✉ care@hubpharmafrica.com ⚡ Same-Day Delivery in Lagos 🌍 Serving patients in 31 countries 💊 10,200+ Chronic Care Patients ✅ NAFDAC & HIPAA Compliant
For HMOs & Payers

Turn Better Adherence Into Measurable Savings

Poor medication adherence quietly drives up claims costs through avoidable hospitalizations and ER visits. Estimate what closing that gap could be worth for your plan - then get a tailored proposal from our partnerships team.

42% Adherence Improvement
95%+ Patient Satisfaction
31 Countries Served

Estimate Your Potential Savings

Enter your chronic-condition enrollee numbers. Every figure updates instantly - adjust the inputs to match your plan.

NGN
Your Estimate
Total current annual chronic-care claimsNGN0
NGN0 - NGN0
Estimated annual cost linked to poor medication adherence - avoidable hospitalizations, ER visits, and disease progression - based on published health-economics research (10-20% of chronic-care spend). HubPharm's coordinated care model is built to close this gap.
42%
HubPharm enrollee adherence rate, vs. a 12% national average
95%+
Patient satisfaction across our coordinated-care population
10,200+
Patients actively managed every month
This is an illustrative model, not a quote. The 10-20% range reflects published research on the cost burden of medication non-adherence, not a HubPharm-specific guarantee. Actual savings depend on your enrollee mix, current programs, and plan design - request a proposal below for numbers tailored to your plan.
How This Works

Built on Real Research, Not Guesswork

The methodology

The 10-20% avoidable-cost range comes from published health-economics research on medication non-adherence - not a HubPharm-specific claim. We show you the assumption, not a black box.

Our track record

Enrollees under HubPharm's coordinated care model reach 42% medication adherence, versus a 12% national average - a figure we publish and can walk you through in detail.

What happens next

Request a proposal and our partnerships team builds a real projection using your actual enrollee data, current programs, and plan design - not just this illustrative estimate.

Adherence-cost research: Iuga & McGuire, Risk Manag Healthc Policy (PMC/NIH); Duke Health Referring Physicians; AdhereTech industry analysis. HubPharm adherence and satisfaction figures are internal data as reported on hubpharmafrica.com. This tool provides an illustrative estimate only.

Frequently Asked

Got Questions?

Everything HMOs and payers ask us before partnering with HubPharm.

✉ Email Us

We multiply your chronic-care enrollee count by your average annual claims cost to get a total spend figure, then apply a 10-20% range drawn from published research on the cost burden of medication non-adherence. It's a directional estimate, not a formula unique to your plan.

No. It's an illustrative model to help you gauge the scale of the opportunity. A real, numbers-backed proposal requires a short conversation about your actual enrollee mix, current programs, and plan design.

Typically: enrollee counts by chronic condition, current claims spend, and where your enrollees are located. We can work with high-level or de-identified data for an initial proposal - no full data-sharing agreement needed to get started.

Any HMO, corporate health plan, or self-insured employer managing enrollees with chronic conditions in Nigeria or the diaspora - HubPharm's coordinated care and delivery network already covers 31 countries.

Hi! I'm Afiya
Chat with me on WhatsApp - I speak Yoruba, Igbo, Hausa, Pidgin & 46 more languages!
Chat with Afiya AI
💊 Talk to a Pharmacist
Get expert medication advice from our licensed pharmacists - available 7 days a week!
Chat with our Pharmacist